Logo image of TESB.BR

TESSENDERLO GROUP (TESB.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:TESB - BE0003555639 - Common Stock

26 EUR
+0.05 (+0.19%)
Last: 1/9/2026, 1:59:30 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to TESB. TESB was compared to 73 industry peers in the Chemicals industry. The financial health of TESB is average, but there are quite some concerns on its profitability. TESB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year TESB has reported negative net income.
In the past year TESB had a positive cash flow from operations.
Each year in the past 5 years TESB has been profitable.
In the past 5 years TESB always reported a positive cash flow from operatings.
TESB.BR Yearly Net Income VS EBIT VS OCF VS FCFTESB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.97%, TESB is doing worse than 68.49% of the companies in the same industry.
TESB has a worse Return On Equity (-1.54%) than 67.12% of its industry peers.
The Return On Invested Capital of TESB (2.45%) is comparable to the rest of the industry.
TESB had an Average Return On Invested Capital over the past 3 years of 6.26%. This is in line with the industry average of 6.84%.
Industry RankSector Rank
ROA -0.97%
ROE -1.54%
ROIC 2.45%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.05%
ROE(5y)10.35%
ROIC(3y)6.26%
ROIC(5y)7.53%
TESB.BR Yearly ROA, ROE, ROICTESB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

In the last couple of years the Profit Margin of TESB has declined.
TESB's Operating Margin of 2.60% is on the low side compared to the rest of the industry. TESB is outperformed by 60.27% of its industry peers.
TESB's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 19.33%, TESB is doing worse than 75.34% of the companies in the same industry.
In the last couple of years the Gross Margin of TESB has declined.
Industry RankSector Rank
OM 2.6%
PM (TTM) N/A
GM 19.33%
OM growth 3Y-39.13%
OM growth 5Y-20.75%
PM growth 3Y-43.54%
PM growth 5Y-21.69%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
TESB.BR Yearly Profit, Operating, Gross MarginsTESB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TESB is destroying value.
TESB has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, TESB has more shares outstanding
Compared to 1 year ago, TESB has a worse debt to assets ratio.
TESB.BR Yearly Shares OutstandingTESB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
TESB.BR Yearly Total Debt VS Total AssetsTESB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.07 indicates that TESB is not a great score, but indicates only limited risk for bankruptcy at the moment.
TESB's Altman-Z score of 2.07 is in line compared to the rest of the industry. TESB outperforms 41.10% of its industry peers.
TESB has a debt to FCF ratio of 2.37. This is a good value and a sign of high solvency as TESB would need 2.37 years to pay back of all of its debts.
The Debt to FCF ratio of TESB (2.37) is better than 91.78% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that TESB is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.06, TESB belongs to the best of the industry, outperforming 87.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.37
Altman-Z 2.07
ROIC/WACC0.34
WACC7.15%
TESB.BR Yearly LT Debt VS Equity VS FCFTESB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

TESB has a Current Ratio of 1.94. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TESB (1.94) is better than 65.75% of its industry peers.
TESB has a Quick Ratio of 1.18. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of TESB (1.18) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.18
TESB.BR Yearly Current Assets VS Current LiabilitesTESB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

TESB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.47%.
Measured over the past years, TESB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.67% on average per year.
The Revenue has been growing slightly by 2.05% in the past year.
Measured over the past years, TESB shows a quite strong growth in Revenue. The Revenue has been growing by 8.72% on average per year.
EPS 1Y (TTM)-131.47%
EPS 3Y-45.67%
EPS 5Y-20.67%
EPS Q2Q%-116.49%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%

3.2 Future

TESB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.97% yearly.
TESB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.77% yearly.
EPS Next Y26.82%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
EPS Next 5YN/A
Revenue Next Year2.34%
Revenue Next 2Y3.91%
Revenue Next 3Y3.83%
Revenue Next 5Y3.77%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TESB.BR Yearly Revenue VS EstimatesTESB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
TESB.BR Yearly EPS VS EstimatesTESB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

TESB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 14.78, which indicates a correct valuation of TESB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TESB indicates a somewhat cheap valuation: TESB is cheaper than 67.12% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.70, TESB is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 14.78
TESB.BR Price Earnings VS Forward Price EarningsTESB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

91.78% of the companies in the same industry are more expensive than TESB, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TESB indicates a rather cheap valuation: TESB is cheaper than 83.56% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.35
EV/EBITDA 5.12
TESB.BR Per share dataTESB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TESB's earnings are expected to grow with 19.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.83%
EPS Next 3Y19.97%

4

5. Dividend

5.1 Amount

TESB has a Yearly Dividend Yield of 2.00%.
TESB's Dividend Yield is comparable with the industry average which is at 2.59.
TESB's Dividend Yield is comparable with the S&P500 average which is at 1.94.
Industry RankSector Rank
Dividend Yield 2%

5.2 History

The dividend of TESB is nicely growing with an annual growth rate of 6.32%!
Dividend Growth(5Y)6.32%
Div Incr Years0
Div Non Decr Years2
TESB.BR Yearly Dividends per shareTESB.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

The earnings of TESB are negative and hence is the payout ratio. TESB will probably not be able to sustain this dividend level.
TESB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-163.64%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
TESB.BR Yearly Income VS Free CF VS DividendTESB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

TESSENDERLO GROUP

EBR:TESB (1/9/2026, 1:59:30 PM)

26

+0.05 (+0.19%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-21 2025-08-21
Earnings (Next)03-24 2026-03-24/amc
Inst Owners6.55%
Inst Owner ChangeN/A
Ins Owners67.43%
Ins Owner ChangeN/A
Market Cap1.56B
Revenue(TTM)2.75B
Net Income(TTM)-27.50M
Analysts74
Price Target27.8 (6.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2%
Yearly Dividend0.89
Dividend Growth(5Y)6.32%
DP-163.64%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.78
P/S 0.57
P/FCF 14.35
P/OCF 5.43
P/B 0.88
P/tB 1.01
EV/EBITDA 5.12
EPS(TTM)-0.45
EYN/A
EPS(NY)1.76
Fwd EY6.77%
FCF(TTM)1.81
FCFY6.97%
OCF(TTM)4.79
OCFY18.41%
SpS45.64
BVpS29.62
TBVpS25.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.97%
ROE -1.54%
ROCE 3.27%
ROIC 2.45%
ROICexc 2.75%
ROICexgc 3.12%
OM 2.6%
PM (TTM) N/A
GM 19.33%
FCFM 3.97%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.05%
ROE(5y)10.35%
ROIC(3y)6.26%
ROIC(5y)7.53%
ROICexc(3y)6.84%
ROICexc(5y)8.72%
ROICexgc(3y)7.62%
ROICexgc(5y)9.8%
ROCE(3y)8.35%
ROCE(5y)10.06%
ROICexgc growth 3Y-43.02%
ROICexgc growth 5Y-19.73%
ROICexc growth 3Y-43.94%
ROICexc growth 5Y-20.03%
OM growth 3Y-39.13%
OM growth 5Y-20.75%
PM growth 3Y-43.54%
PM growth 5Y-21.69%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
F-Score6
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.37
Debt/EBITDA 0.38
Cap/Depr 79.91%
Cap/Sales 6.52%
Interest Coverage 7.13
Cash Conversion 97.53%
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.18
Altman-Z 2.07
F-Score6
WACC7.15%
ROIC/WACC0.34
Cap/Depr(3y)86.48%
Cap/Depr(5y)81.96%
Cap/Sales(3y)5.78%
Cap/Sales(5y)5.54%
Profit Quality(3y)142.64%
Profit Quality(5y)138.54%
High Growth Momentum
Growth
EPS 1Y (TTM)-131.47%
EPS 3Y-45.67%
EPS 5Y-20.67%
EPS Q2Q%-116.49%
EPS Next Y26.82%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
EPS Next 5YN/A
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%
Revenue Next Year2.34%
Revenue Next 2Y3.91%
Revenue Next 3Y3.83%
Revenue Next 5Y3.77%
EBIT growth 1Y11.41%
EBIT growth 3Y-34.05%
EBIT growth 5Y-13.84%
EBIT Next Year250.49%
EBIT Next 3Y60.07%
EBIT Next 5Y41.73%
FCF growth 1Y86.64%
FCF growth 3Y-0.02%
FCF growth 5Y5.66%
OCF growth 1Y36.82%
OCF growth 3Y10.31%
OCF growth 5Y8.67%

TESSENDERLO GROUP / TESB.BR FAQ

Can you provide the ChartMill fundamental rating for TESSENDERLO GROUP?

ChartMill assigns a fundamental rating of 4 / 10 to TESB.BR.


Can you provide the valuation status for TESSENDERLO GROUP?

ChartMill assigns a valuation rating of 5 / 10 to TESSENDERLO GROUP (TESB.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for TESSENDERLO GROUP?

TESSENDERLO GROUP (TESB.BR) has a profitability rating of 2 / 10.


What is the earnings growth outlook for TESSENDERLO GROUP?

The Earnings per Share (EPS) of TESSENDERLO GROUP (TESB.BR) is expected to grow by 26.82% in the next year.


How sustainable is the dividend of TESSENDERLO GROUP (TESB.BR) stock?

The dividend rating of TESSENDERLO GROUP (TESB.BR) is 4 / 10 and the dividend payout ratio is -163.64%.